Finance Data Analyst, Docplanner
+ Share options plan after 6 months of working with us
Booking platform and management software provider for doctors
Job no longer available
Booking platform and management software provider for doctors
1001+ employees
Job no longer available
+ Share options plan after 6 months of working with us
1001+ employees
Company mission
To make the healthcare experience more human, via free doctor reviews and bookings for patients, and practice management tools for doctors.
Jump to section
Company mission
To make the healthcare experience more human, via free doctor reviews and bookings for patients, and practice management tools for doctors.
Our take
Healthcare platform Docplanner has become a major player in the European healthtech market in the decade since it was founded. The company offers a suite of administrative tools for 30M patients and around 2M doctors worldwide, including workflow digitisation and appointment booking services. The company currently operate in 13 countries, hit Unicorn status in 2021, and has been riding a recent wave of digital transformation and workforce overburdening in the healthcare sector which has spurred on demand for precisely the kind of services they provide. So it’s safe to say business is going well.
What is most compelling about Docplanner’s business journey has been its long-brewing competition with their direct competitor, the fellow Unicorn and better-funded Doctolib. The tête-à-tête with this French/German rival has seen both parties making aggressive European expansion with national acquisitions - Doctolib in Italy, France, and Germany; Docplanner in Turkey, Poland, Spain, and Latin America. With Docplanner’s 2021 acquisition of German parallel platform Jameda, however, they are making moves on Doctolib’s home turf. The company has also acquired MyDr, a leading Polsih tech solutions provider.
These broad consolidation moves represent a maturation of the healthtech market which will serve both competitors well. Docplanner is certainly a key and aggressive contender in this race - and this company isn't going anywhere any time soon.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Stock Option plan
- Flexible working hours
- Off days package
- English classes
- Free health insurance & wellnes Ifeel platform (unlimited)
- Corporate access with Andjoy colaboration
- Additional paid holiday on your birthday to celebrate with your loved ones or to have a self-care day!
- Working from home policy (up to 3 days per week)
Company values
- Leave your comfort zone
- Focus on results not tasks
- Give feedback now, directly
- Keep it simple
- Do what you love
- Hustle, hit, never quit
Funding (last 2 of 6 rounds)
May 2019
$83.2m
SERIES E
May 2017
$15.6m
SERIES D
Total funding: $131.8m
This company has top investors
Leadership
Mariusz Gralewski
(CEO)A Computer Science graduate from Warsaw University of Technology.
Luca Puccioni
(CEO)Previously Vice President and Chief Sales Officer at Groupon, he subsequently worked as Director for Southern European Sales at HomeAway.
Lucek Samulowski
(CPO)Previously Senior HR Business Partner at Unilever, he went on to serve as Head of HR at GoldenLine Sp.
Articles
Jobs (22)
Software Engineering
Operations & Strategy
Sales & Account Management